HighMark Wealth Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
HighMark Wealth Management's RGEN Position: Q2 2022 in Review
HighMark Wealth Management sold out of Repligen (RGEN) in Q2 2022, closing a stake of 14 shares — an estimated $3K sold.
HighMark Wealth Management first reported a position in RGEN in Q3 2021 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.
- HighMark Wealth Management reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
- HighMark Wealth Management sold 14 Repligen shares in Q2 2022, an estimated $3K.
- HighMark Wealth Management first reported a position in Repligen in Q3 2021 and held it in 3 quarters.
- HighMark Wealth Management's Repligen position peaked at $4K in Q4 2021.
- 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.
Based on HighMark Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.